Literature DB >> 3098470

Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marrow cells from myeloma patients mediated by T cell dependent mitogens.

D Peest, S Gasch, C Thiele, B Bartels, U Brunkhorst, I Dallmann, M Hoffmann, I Schedel, H Deicher.   

Abstract

In vitro monoclonal immunoglobulin (mIg) production of cultured tumour cells--prepared from the bone marrow (BM) or from the peripheral blood (PB) of 40 multiple myeloma (MM) patients, 16 patients with monoclonal gammopathy of undetermined significance and two patients with M. Waldenström--was measured with an enzyme-linked immunosorbent assay (ELISA) using anti-idiotype and anti-class specific antisera. After in vitro stimulation with pokeweed mitogen (PWM) or OKT3 antibody, mIg production was regularly suppressed in BM cell cultures, whereas enhanced, unaltered or suppressed production was observed in PB cell cultures. These observations show that the expanded clone in MM can still be regulated in vitro. Separation experiments demonstrated the involvement of T cells in this in vitro system. The results could be explained by the hypothesis that activated T cells can suppress mature cells of B cell differentiation, as found in BM of the patients, but stimulate earlier B cells from the peripheral blood towards differentiation into Ig secreting cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098470      PMCID: PMC1542271     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

Review 1.  Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation.

Authors:  R G Lynch; J W Rohrer; B Odermatt; H M Gebel; J R Autry; R G Hoover
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

Review 2.  Antigen and T lymphocyte mediated suppression of myeloma cells: model systems for regulation of lymphocyte function.

Authors:  A K Abbas
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  The T cell dependence of B cell differentiation induced by pokeweed mitogen.

Authors:  R G Keightley; M D Cooper; A R Lawton
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

Review 4.  Idiotypic immunoglobulin structures on blood lymphocytes in human plasma cell myeloma.

Authors:  G Holm; H Mellstedt; D Pettersson; R Biberfeld
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

5.  The protein-A plaque assay: a new system for the detection of cells secreting a given idiotype.

Authors:  L Hammarström; C I Smith; D Pettersson; H Mellstedt; G Holm
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

6.  Prevention of myeloma growth in BALB-c mice by injection of anti-immunoglobulin antisera.

Authors:  D D Manning; J W Jutila
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

7.  Regulation of monoclonal immunoglobulin G synthesis by antiidiotypic antibody in a patient with hypogammaglobulinemia.

Authors:  F Mudawwar; Z Awdeh; K Ault; R S Geha
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

8.  Idiotype-bearing peripheral blood lymphocytes in human multiple myeloma and Waldenström's macroglobulinaemia.

Authors:  I Schedel; D Peest; K Stünkel; M Fricke; G Eckert; H Deicher
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  Cytostatic drug sensitivity test for human multiple myeloma, measuring monoclonal immunoglobulin produced by bone marrow cells in vitro.

Authors:  D Peest; B Bartels; I Dallmann; I Schedel; H Deicher
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation.

Authors:  H Kubagawa; L B Vogler; J D Capra; M E Conrad; A R Lawton; M D Cooper
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  2 in total

1.  Effect of interleukin-2 on the ex vivo growth of human myeloma cells.

Authors:  D Peest; I de Vries; R Hölscher; R Leo; H Deicher
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Cytostatic drug sensitivity test for human multiple myeloma, measuring monoclonal immunoglobulin produced by bone marrow cells in vitro.

Authors:  D Peest; B Bartels; I Dallmann; I Schedel; H Deicher
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.